# BRIGHT MINDS BIOSCIENCES INC (DRUG)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/DRUG/

- Reporting holders: 4
- Reported value: $4.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $2.3K | 47 | 0.0% | 1 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $2.3K | 46 | 0.0% | 3 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $50 | 1 | 0.0% | 1 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $50 | 1 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $4.7K |
| Q2 2026 | 101 | $668.3M |
| Q1 2026 | 93 | $674.1M |
| Q4 2025 | 74 | $514.9M |
| Q3 2025 | 63 | $366.4M |
| Q2 2025 | 47 | $137.0M |
| Q1 2025 | 34 | $188.4M |
| Q4 2024 | 31 | $176.4M |
| Q3 2024 | 6 | $229.8K |
| Q2 2024 | 6 | $208.2K |
| Q1 2024 | 7 | $255.6K |
| Q4 2023 | 7 | $329.8K |